CD14 and COVID-19: During severe COVID-19, upregulated genes in both CD14 and CD16 monocyte cells were associated with type I interferon signaling, response to the virus, positive regulation of cytokine production, and toll-like receptor (TLR) signaling pathways (Figure 1D).